PODCAST

Neuro Frontiers CME

ReachMD

science & medicine medicine

All Episodes

00:00:00

Exploring the Impact of Insomnia on Daytime...

Neuro Frontiers CME ·

2023/09/29

Host: Michael E. Yurcheshen, MD, FAASM Host: Kevin Trice, MD Insomnia is characterized by difficulty falling asleep, staying asleep, and experiencing non-restorative or poor-quality sleep; it often leaves individuals feeling unrefreshed upon awakening. Symptoms during the day may include fatigue, irritability, impaired focus, and excessive sleepiness. The condition can significantly deteriorate a person’s quality of life, leading to reduced productivity, impaired cognitive

00:00:00

Integrating Evidence and Cultural Sensitivity in...

Neuro Frontiers CME ·

2023/09/29

Host: Kevin Trice, MD Host: Michael E. Yurcheshen, MD, FAASM Insomnia is characterized by difficulty falling asleep, staying asleep, and experiencing non-restorative or poor-quality sleep; it often leaves individuals feeling unrefreshed upon awakening. Symptoms during the day may include fatigue, irritability, impaired focus, and excessive sleepiness. The condition can significantly deteriorate a person’s quality of life, leading to reduced productivity, impaired cognitive

00:00:00

Examining Treatment Options for Insomnia: From Orexin...

Neuro Frontiers CME ·

2023/09/29

Host: Kevin Trice, MD Insomnia is characterized by difficulty falling asleep, staying asleep, and experiencing non-restorative or poor-quality sleep; it often leaves individuals feeling unrefreshed upon awakening. Symptoms during the day may include fatigue, irritability, impaired focus, and excessive sleepiness. The condition can significantly deteriorate a person’s quality of life, leading to reduced productivity, impaired cognitive function, mood disturbances, and an increased risk

00:00:00

Sleep Architecture and Neurotransmitters of Sleep

Neuro Frontiers CME ·

2023/09/29

Host: Michael E. Yurcheshen, MD, FAASMInsomnia is characterized by difficulty falling asleep, staying asleep, and experiencing non-restorative or poor-quality sleep; it often leaves individuals feeling unrefreshed upon awakening. Symptoms during the day may include fatigue, irritability, impaired focus, and excessive sleepiness. The condition can significantly deteriorate a person’s quality of life, leading to reduced productivity, impaired cognitive function, mood disturbances, and

00:00:00

Patient Perspective: Living With Insomnia

Neuro Frontiers CME ·

2023/09/29

00:00:00

Utilizing Assessment Tools in Insomnia

Neuro Frontiers CME ·

2023/09/29

Host: Michael E. Yurcheshen, MD, FAASM Insomnia is characterized by difficulty falling asleep, staying asleep, and experiencing non-restorative or poor-quality sleep; it often leaves individuals feeling unrefreshed upon awakening. Symptoms during the day may include fatigue, irritability, impaired focus, and excessive sleepiness. The condition can significantly deteriorate a person’s quality of life, leading to reduced productivity, impaired cognitive function, mood disturbances, and

00:00:00

New Treatments for Residual Excessive Daytime...

Neuro Frontiers CME ·

2023/08/25

Host: Christina Finch, MD This curriculum focuses on the recognition and management of excessive daytime sleepiness (EDS) in patients with treated obstructive sleep apnea (OSA). Evidence-based treatment strategies for OSA will be reviewed, including best practices for the use of novel pharmacotherapeutics in the management of persistent EDS caused by OSA.

00:00:00

How to Identify Residual Excessive Daytime Sleepiness...

Neuro Frontiers CME ·

2023/08/25

00:00:00

Algorithm for Assessing Excessive Daytime Sleepiness...

Neuro Frontiers CME ·

2023/08/25

Host: Neomi Shah, MD, MPH, MSc This curriculum focuses on the recognition and management of excessive daytime sleepiness (EDS) in patients with treated obstructive sleep apnea (OSA). Evidence-based treatment strategies for OSA will be reviewed, including best practices for the use of novel pharmacotherapeutics in the management of persistent EDS caused by OSA.

00:00:00

Case Study: Adjusting STOP-BANG Screening Criteria...

Neuro Frontiers CME ·

2023/08/25

00:00:00

Negative Impacts of Excessive Daytime Sleepiness Due...

Neuro Frontiers CME ·

2023/08/25

00:00:00

Experts Debate: How Novel Excessive Daytime...

Neuro Frontiers CME ·

2023/08/25

Host: Atul Malhotra, MD Host: Neomi Shah, MD, MPH, MSc This curriculum focuses on the recognition and management of excessive daytime sleepiness (EDS) in patients with treated obstructive sleep apnea (OSA). Evidence-based treatment strategies for OSA will be reviewed, including best practices for the use of novel pharmacotherapeutics in the management of persistent EDS caused by OSA.

00:00:00

Roundtable: Safety and Efficacy Data on New Therapies...

Neuro Frontiers CME ·

2023/08/25

00:00:00

The Epidemiology of Sleepiness in Obstructive Sleep...

Neuro Frontiers CME ·

2023/08/25

Host: Atul Malhotra, MD This curriculum focuses on the recognition and management of excessive daytime sleepiness (EDS) in patients with treated obstructive sleep apnea (OSA). Evidence-based treatment strategies for OSA will be reviewed, including best practices for the use of novel pharmacotherapeutics in the management of persistent EDS caused by OSA.

00:00:00

Roundtable: Experts Recommend Tools to Diagnose and...

Neuro Frontiers CME ·

2023/08/25

Host: Atul Malhotra, MD Host: Christina Finch, MD This curriculum focuses on the recognition and management of excessive daytime sleepiness (EDS) in patients with treated obstructive sleep apnea (OSA). Evidence-based treatment strategies for OSA will be reviewed, including best practices for the use of novel pharmacotherapeutics in the management of persistent EDS caused by OSA.

00:00:00

Understanding the Fine Print: The Who, When, And What...

Neuro Frontiers CME ·

2023/07/27

Host: James Galvin, MD, MPH, FANA Guest: Jon Toledo, MD, PhD Recently, Alzheimer’s Disease (AD) saw its first approvals for disease modifying therapy (DMT). With amyloid-beta (Aβ) targeting DMT now a reality, the entire way this condition is viewed and managed is changing. In particular, amyloid-related imaging abnormalities (ARIA), the most common adverse effects seen in DMT trials, are unique to this agent class, raising new questions and considerations across multiple medical

00:00:00

Understanding the Fine Print: The Who, When, And What...

Neuro Frontiers CME ·

2023/05/15

Host: James Galvin, MD, MPH, FANA Guest: Gloria Chiang, MD Guest: Christopher Carpenter, MD, MSC, FACEP, FAAEM, AGSF Guest: Charles P. Vega, MD Recently, Alzheimer’s Disease (AD) saw its first approvals for disease-modifying therapy (DMT). With amyloid-beta (Aβ) targeting DMT now a reality, the entire way this condition is viewed and managed is changing. In particular, amyloid-related imaging abnormalities (ARIA), the most common adverse effects seen in DMT trials, are

00:00:00

Battle of the Biomarkers: Assessing Key Factors in...

Neuro Frontiers CME ·

2023/03/21

Host: Robert Shin, MD, FANA, FAAN Guest: Jiwon Oh, MD, PhD, FRCPC Guest: Enrique Alvarez, MD, PhD Over the past several years, the image of MS has been changing from distinct categories of disease to a complicated spectrum of interwoven pathologies. As this knowledge evolves, so do approaches to prognosticating, monitoring, and responding to disease. With many markers of progression still under investigation and therefore not included in modern guidelines, MS clinicians are

18 results

Neuro Frontiers CME

All Episodes

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事